Despite the two groups showing similar values for Ki67, mitotic count, and tumor stage at diagnosis, patients with OAC had a 5-year survival rate of 87.9%, significantly higher than that of patients with conventional ACC. This evidence concerns the gene MKI67 and adrenal cortex carcinoma.